FHIR Release 3 (STU)

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0317

Pharmacy Work Group

Maturity Level: N/A

Ballot Status: Informative

Compartments: Patient, Practitioner

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile MedicationDispense.

Generated Narrative with Details

id: meddisp0317

contained:

status: stopped

medication: Brentixumab Vedotin (Adcetris). Generated Summary: id: med0306; Adcetris (Brentuximab Vedotin 50mg/10.5ml) (Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris (Brentuximab Vedotin 50mg/10.5ml)'}); isBrand; Lyophilized powder for injectable solution (qualifier value) (Details : {SNOMED CT code '421637006' = 'Lyophilised powder for injectable solution', given as 'Lyophilized powder for injectable solution (qualifier value) '})

subject: Donald Duck

Performers

-

Actor

OnBehalfOf

*

Practitioner/f006

Organization/2.16.840.1.113883.19.5

authorizingPrescription: MedicationRequest/medrx0316

type: Trial Fill (Details : {http://hl7.org/fhir/v3/ActCode code 'TF' = 'Trial Fill', given as 'Trial Fill'})

quantity: 3 415818005 (Details: SNOMED CT code 415818005 = '415818005')

daysSupply: 1 Day (Details: UCUM code d = 'd')

whenPrepared: 25/06/2015 7:13:00 AM

whenHandedOver: 26/06/2015 7:13:00 AM

dosageInstruction:

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.